Journal Home
Search for

Volume 37, Issue 5, Pages 445-454 (November 2009)


View previous. 11 of 17 View next.

Clinical Preventive Services for Adolescents

Leif I. Solberg, MDaCorresponding Author Informationemail address, James D. Nordin, MD, MPHa, Tracie L. Bryantb, Alyson Hazen Kristensen, MPHb, Susan K. Maloney, MHSb

Context

Most of the many clinical preventive services (CPS) recommended for adolescents by various national organizations lack good evidence of effectiveness. Improving adolescent preventive care will require focusing on those CPS for which there is such evidence and on developing better delivery strategies. The objective of the current study was to identify those CPS for adolescents that do have a strong evidence base, to update the literature review and summarize evidence gaps where research is needed, and to summarize current delivery prevalence and opportunities.

Evidence acquisition

A summary was conducted of the recommendations for adolescents of the U.S. Preventive Services Task Force (USPSTF) and the CDC's Advisory Committee on Immunization Practices (ACIP). An update is provided of the literature review for services with an inadequate evidence base to support a recommendation. A summary was prepared of the types of evidence still needed. A literature search was also conducted for current delivery prevalence of recommended services for those aged 11–17 years, and common gaps in the evidence were identified.

Evidence synthesis

Although 24 CPS for adolescents have been reviewed by the USPSTF, only ten received definite recommendations and only seven of these favored delivery of the service. In addition, the ACIP recommends four immunizations for all adolescents, and two additional ones for those at high risk. There are many gaps in the evidence supporting most of the other services as well as in the information about current delivery prevalence.

Conclusions

There are too many CPS recommended for adolescents with insufficient evidence of effectiveness, and there is low delivery prevalence for the few services with good evidence of effectiveness. Both more research and more attention to the practice changes that might improve delivery prevalence are needed.

Article Outline

Abstract

Introduction

Methods

Results

Literature Updates

Evidence Gaps and Unknowns

Current Delivery Prevalence

Opportunities for Prevention

Discussion

Recommendations

Conclusion

Acknowledgment

References

Copyright

Introduction 

return to Article Outline

Prevention is receiving more national attention, both because the most common underlying causes of death are preventable and because of the growing costs of treating existing conditions.1, 2, 3, 4 Even though there are many important population-based prevention actions that can and should be taken in communities, there is also need for improvement in clinical preventive services (CPS)—those usually delivered in clinical care settings.

As CPS gain importance, the recommendations for them have grown in number and in complexity, especially those targeting children and adolescents. Some recommendations also conflict with each other, especially those from organizations that rely on expert opinion. Currently, 28 counseling services and 31 screening services are recommended for adolescents by at least one of the five national groups that issue comprehensive sets of prevention recommendations: American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American Academy of Pediatrics (AAP; Bright Futures); American Medical Association (AMA; Guidelines for Adolescent Preventive Services [GAPS]); and the U.S. Preventive Services Task Force (USPSTF). These 59 CPS do not include the ten immunizations recommended by the CDC's Advisory Committee on Immunization Practices (ACIP). In a review5 of the evidence behind the CPS that are recommended by at least two of the five organizations for well-child care, it was found that most had limited supporting evidence. The authors pointed out that because poorly evidenced recommendations can cause harm (at least by displacing more effective activities during all-too-brief clinical encounters), “all recommendations should be based on the strongest possible evidence.”

The USPSTF is clearly recognized as the body that does the best and most transparent job of basing recommendations on research evidence of effectiveness in a clinical setting. Although the stringent requirements of the USPSTF have reduced the number of recommended CPS, it is still difficult to fit this more limited set of services into well-child visits. It has been calculated6 that in a typical primary care practice, delivery of only USPSTF-recommended CPS for adolescents would take about 40 minutes per year per adolescent. This time period is well beyond that available within the 0.2 preventive visits per year reported7 as being currently utilized by this age group on average.

For adults, this problem of the volume and complexity of CPS has been greatly helped by the efforts of the National Commission on Prevention Priorities to objectively and transparently prioritize those preventive services with evidence of effectiveness. The resulting priority ranking and its recent updating allows patients, clinicians, care systems, payers, and purchasers to know where their resources and time will have the greatest impact.8, 9

For adolescents, however, delivery of CPS is associated with a number of unique problems that make improvement difficult:


1.There are more services recommended for adolescents by various advocacy organizations than for adults/other age groups.

2.Only a small proportion of these recommended services have enough evidence to allow either assurance that they are effective or prioritization among them.5

3.More than for adults, clinician delivery of preventive services to adolescents tends to be driven by tradition, expert opinion, and the very limited needs of particular required preventive visits (e.g., school or sports physicals).

4.Existing data on the frequency of clinician visits by adolescents (especially preventive visits) are both limited and outdated.10, 11, 12, 13

5.Many clinicians feel that adolescents are less interested in their long-term health than adults, more likely to engage in risky behaviors, and less likely to heed clinician recommendations.14, 15, 16

6.The time scheduled for adolescent routine exams is usually quite short, and extending it is unlikely, given that the Centers for Medicare and Medicaid Services (CMS) has recently increased the relative value for nonpreventive visits, thereby effectively reducing reimbursement for preventive visits.

Despite these problems and the fact that most adolescents are healthy, more than 70% of adolescent morbidity and mortality is the result of risky behaviors, such as alcohol use, unsafe sex, and violence. In addition, behavioral patterns established in adolescence, such as poor nutrition, physical inactivity, and tobacco use, contribute to cardiovascular disease, diabetes, and cancer in adulthood.5 The clinical setting presents an opportunity to identify risky behaviors early and to steer adolescents in the right direction.

In order to clarify the situation for adolescent CPS, this paper has the following objectives:


1.to identify those CPS for adolescents that do have a strong evidence base (i.e., have been recommended by the USPSTF or the ACIP);

2.to update the literature review concerning those adolescent CPS with insufficient evidence for a clear recommendation and to summarize the evidence gaps where research is needed;

3.to summarize what is known about current delivery prevalence for these CPS, as well as opportunities to provide them during medical visits.

Finally, based on the results of these objectives, along with the relevant quality-improvement literature, actions that might lead to improvements were identified.

Methods 

return to Article Outline

Because many CPS for adults begin at age 18 years, this review was limited to those CPS applicable to those aged 11–17 years. As of May 2009, only seven CPS have received positive recommendations from the USPSTF. In addition, the USPSTF relies on the ACIP for recommendations for immunizations. As of May 2009, the ACIP was recommending four immunizations for all adolescents aged 11–18 years, plus two others for certain high-risk groups.17 These 13 CPS are listed in Table 1.

Table 1.

Adolescent clinical preventive services recommended by the USPSTF or ACIP

ServiceGradeRelease dateTargeted population
Cervical cancer (Pap)AJanuary 2003Sexually active women with a cervix
Chlamydia (girls)AJune 2007Sexually active women aged <25 years
DepressionBApril 2009Adolescents
TobaccoBMay 2008Adolescents
GonorrheaBMay 2005Sexually active women at increased risk
SyphilisAJuly 2004People at any age at increased risk for any sexually transmitted infections
HIVAApril 2007People at any age at increased risk
Tdap, influenza, and meningococcal vaccinesN/A Adolescents
HPV vaccineN/A Adolescent girls
For those at increased risk
Pneumococcal and hepatitis A vaccineN/A People at increased risk

ACIP, Advisory Committee on Immunization Practices; HPV, human papillomavirus; USPSTF, U.S. Preventive Services Task Force

The recommendations of the USPSTF are based on a set of letter grades reflecting its assessment of a combination of the strength of evidence and the balance between benefits and harms. The current definitions are as follows18:


A.Recommends. High certainty of substantial net benefit.

B.Recommends. High certainty that net benefit is moderate or moderate certainty that benefit is moderate to substantial.

C.Recommends against routine provision, but may be appropriate for individuals. At least moderate certainty of small net benefit.

D.Recommends against. At least moderate certainty of no net benefit or that harms outweigh benefits.

I.Current evidence is insufficient to assess the balance of benefits and harms.

The literature was reviewed to provide a current update for those CPS with an I or C grade where the latest USPSTF review was conducted prior to June 2006. Immunization reviews were not updated as the ACIP keeps those reviews current. The review update followed this sequence:


1.Review the USPSTF recommendation statement to clarify the service.

2.Review the USPSTF evidence synthesis.

3.Develop a list of medical subject headings (MeSH) search terms.

4.Search PubMed through April 23, 2008, using those MeSH terms from the last date reviewed for the USPSTF. Other limits were abstracts, humans, English, and adolescents.

5.Search Cochrane Database of Systematic Reviews through 2007 (Cochrane Collaboration does not allow searches to limit dates to a specific month or day), using those MeSH terms from the past year reviewed for the USPSTF evidence review.

6.Review relevant articles cited in the bibliographies of articles from the above searches.

In order to identify research gaps and improvement actions, the USPSTF's systematic evidence reviews, evidence syntheses, and recommendation statements were first reviewed. During these reviews, barriers were identified that the USPSTF identified as preventing it from issuing a definite recommendation for each service, most of which were research gaps. Then information obtained from the update review process was added, and the main evidence gaps were summarized. Because most recommended CPS require face-to-face encounters in medical settings, a literature review was also conducted to clarify what is known about current opportunities to provide any CPS during medical visits, both those scheduled as well visits (e.g., school and sports physicals) and those generated for other reasons.

A review of current delivery prevalence was conducted by searching PubMed for adolescent clinical preventive services as well as the individual service topics. First, abstracts of relevant articles were reviewed to determine if information about delivery prevalence was included. If it was, the full article was reviewed, as well as any cited articles that were published through 2007. Little information is available about the prevalence of these services, so there was no need to apply selection criteria—anything found in multiple searches was included.

Results 

return to Article Outline

The screening and counseling services recommended for adolescents aged 11–17 years by the USPSTF or the ACIP are summarized in Table 1. Table 2 contains the other services reviewed by the USPSTF but not recommended. The only other immunizations recommended by the ACIP for adolescents (hepatitis B, inactivated poliovirus, measles, mumps, rubella, and varicella) are identified for catch-up if not received previously. Twenty-four adolescent preventive services other than immunizations have been reviewed by the USPSTF, but only ten received definite recommendations (i.e., A, B, or D grades), and only seven services were given A or B grades, indicating that there is a high certainty of benefit. The other three were given D grades, indicating that they should not be performed. Most of the services receiving A or B grades involve sexually transmitted infections (STIs) or cervical cancer. Many of the services with insufficient evidence for adolescents had enough evidence to be recommended for adults by the USPSTF. Comparable adolescent services received an I grade because usually either the studies reviewed were limited to adults or findings for adolescents were not reported separately even though some adolescents may have been included in the study population. Among the ten immunizations recommended by the ACIP, three are recommended for all adolescents, namely conjugated meningococcal vaccine, Tdap, and influenza; one, human papillomavirus (HPV), is recommended for girls only. Four are “catch-up” recommendations for those who were not immunized at the recommended ages, and two are for high-risk groups only. Influenza had been recommended for high-risk groups only, but the June 2008 ACIP meeting recommended it for all adolescents.

Table 2.

Other adolescent clinical preventive services reviewed by the USPSTF

ServiceGradeRelease dateTargeted population
OverweightIJuly 2005Children and adolescents
Suicide riskIMay 2004General population
Alcohol misuseIApril 2004Adolescents
Chlamydia (boys)IJune 2007Boys/men
Gonorrhea (boys)IMay 2005Sexually active men aged <25 years
HIV (low-risk)CApril 2007People not at increased risk
Lipid disordersIJuly 2007Children and young adults aged <21 years
Illicit drug useIJanuary 2008General population
Testicular cancerDFebruary 2004Asymptomatic adolescent and adult boys/men
Idiopathic scoliosisDJune 2004Adolescents
Syphilis (low-risk)DJuly 2004Asymptomatic people not at increased risk
Physical activityIAugust 2002General population
Healthy dietIJanuary 2003General population without risk factors for cardiovascular or diet-related disease
Skin cancerIOctober 2003General population
HIV and STIsC1996*Adolescents and adults
Auto restraintsIAugust 2007General population
Alcohol and autosIAugust 2007General population

STIs, sexually transmitted infections; USPSTF, U.S. Preventive Services Task Force

Literature Updates 

Five of the remaining 14 services with either insufficient evidence (I grade) or no recommendation (C grade) have been reviewed and updated by the USPSTF since June 2007, with no change in status. Updated literature searches of the nine other services produced the 19 articles listed in Table 3, Table 4.. Although the search strategies identified 20–1000 articles for each service, limiting these lists to those including adolescents, English language, an abstract, and the appropriate date range reduced these lists to two to 39 articles per service. Reviews of those abstracts further reduced potential articles to zero to six articles per service. Most abstracts were rejected because the studies did not include adolescents, did not address the evidence gaps, or addressed an intervention not feasible in the clinical practice setting. Five addressed delivery prevalence only and two were pilot studies. The meta-analyses, reviews, and clinical trials had mostly weak, mixed, or negative findings. In all cases, the additional studies found were not sufficient to warrant a definite recommendation.

Table 3.

Literature review updates for screening tests for adolescents

ServiceDatesArticles identifiedRelevant articlesSample (age in years)Findings
OverweightApril 2005–April 20088Taveras (2007)19324(10–18)Report infrequent specific doctor weight counseling
Klein (2006)208,384(14–18)One third at risk or overweight and report frequent doctor counseling
Suicide riskOctober 2002–April 200839Miranda (2008)21191(teens)In 4–6 years, 17% screened and made attempts
Folse (2006)22104(12–82)Pilot study of four-item screen in emergency rooms
Gould (2005)232,342(teens)No evidence screening increases distress or suicidal thoughts
Alcohol misuseFebruary 2003–April 200811Boekeloo (2004)24409(12–17)RCT of brief office intervention had no effect on use
Gonorrhea (boys)July 2004–April 200816Peterman (2006)251,183(15–39)3-month check after STI clinic treatment: 15% new STI
Gaydos (2006)2616,850(40%<19)0%–1.5% of asymptomatic men tested in medical clinics had gonorrhea
HIV (low-risk)June 2004–April 2008180

STI, sexually transmitted infection

Table 4.

Literature review updates for counseling services for adolescents

ServiceDatesArticlesRelevant articlesSample (age in years)Findings
Physical activityMarch 2002–April 200811Ma (2005)11NAMCS (13–18)Only 22% report activity counseling during physicals
Ortega (2004)27392(12–21)Those counseled at 0, 6, and 12 months increased activity
Patrick (2006)28878(11–15)DOCTOR advice and 12 monthly mailings increased activity
Healthy dietJanuary 2000–April 200812Ma (2005)11NAMCS (13–18)Only 26% reported diet counseling during physicals
Patrick (2001)29117(11–18)PACE intervention is feasible
Skin cancerAugust 2002–April 20082Norman (2007)30819(11–15)RCT: DOCTOR counseling and periodic materials increased recorded behaviors
HIV and STIsJanuary 1994–April 200815Sussman (2007)3137 cliniciansInterviews identified problems for HPV counseling
Roye (2007)32400(teens)RCT: video and counseling did not increase condom use at 1 year.
Jemmott (2005)33682(teens)RCT: CBT or information was ineffective, skills-based both effective and ineffective
Sales (2006)34Systematic review39 studies suggest there are effective interventions
Boekeloo (1999)35197(12–15)RCT: at 9 months, no difference in behaviors but increased STIs

CBT, cognitive–behavioral therapy; NAMCS, National Ambulatory Medical Care Survey; PACE, Prescriptive Adherence Counseling and Education; STIs, sexually transmitted infections

Tobacco cessation counseling has recently moved from insufficient evidence (i.e., an I grade) to a B recommendation for adolescents on the strength of additional studies as reviewed by the U.S. Public Health Services guideline group (which the USPSTF defers to), which released its updated recommendations in May 2008.36 After conducting a meta-analysis of seven trials involving adolescents, it concluded that: “Counseling has been shown to be effective in treatment of adolescent smokers. Therefore, adolescent smokers should be provided with counseling interventions to aid them in quitting smoking.” However, only two of the seven trials in their meta-analysis addressed typical adolescents in medical settings, and those two were in emergency departments. Thus, one could still question whether the intervention benefit would apply in primary care. Nevertheless, in a well-designed RCT of 2526 teens making primary care visits that was not selected for that meta-analysis, it was demonstrated37 in 2005 that brief physician advice followed by two phone calls could increase prolonged cessation.

Similarly, depression screening for adolescents moved from an I to a B rating, based on a USPSTF update review. However, in its recommendation statement, the USPSTF said, “The USPSTF recommends screening of adolescents (aged 12–18 years) for major depressive disorder (MDD) when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive–behavioral or interpersonal), and follow-up.”38 Thus, the recommendation currently will apply to only those few clinics that have such systems in place.

Evidence Gaps and Unknowns 

Summarizing the evidence gaps identified by the USPSTF that prevented I- and C-grade services from receiving an A- or B-grade recommendation demonstrated that a relatively common set of gaps was present. For both counseling and screening services, the main problem was inadequate evidence about the effect of delivering the service to adolescents in primary care settings on either short-term (patient behaviors) or long-term outcomes (morbidity and mortality). There was also little evidence about the acceptability or harms of tests, interventions, or subsequent treatments. Although there may be evidence to allow a balancing of benefits versus harms for adults, that evidence was generally lacking for adolescents. In nearly all cases, the problem was less a lack of clarity among existing trials than an absence of any good scientific studies about realistic clinical interventions in adolescents.

Current Delivery Prevalence 

The estimates of current delivery prevalence for all the services relevant for adolescents from the literature search conducted for the current study are summarized in Table 5. The three services given D recommendations (screening for scoliosis, testicular cancer, and those at low risk for syphilis) are omitted, in part because no data were found about their frequency of delivery. Identifying prevalence specific to adolescents that might be representative of national averages was especially difficult. For many of the services, only survey-based self-reports of physicians were available. The population or sample represented by the data in this sample varied from one study to another, so it was impossible to directly compare the prevalence of different services unless they came from the same study. With the possible exception of Paps, delivery prevalence for all services is low, especially considering that self-reported prevalences from physician surveys are probably considerably higher than they are in reality.

Table 5.

Current frequency of preventive services in adolescents

ServiceDelivery frequencySource
Screening
Cervical cancer (Pap)HEDIS population=81% commercial and 66% MedicaidHEDIS (2007)39
Chlamydia (girls)HEDIS for ages 16–20 years=36% commercial and 50% for MedicaidHEDIS (2007)39
Gonorrhea (girls)30% of primary care doctors report screeningSt. Lawrence (2002)40
Syphilis (high-risk)20% of primary care doctors report screeningSt. Lawrence (2002)40
HIV (high-risk)26% of primary care doctors report screeningSt. Lawrence (2002)40
Overweight55% of doctors report screeningHalpern-Felsher (2000)41
Depression36% of those aged 13–17 years report being screenedOzer (2007)42
17% of doctors report screeningHalpern-Felsher (2000)41
Suicide risk15% of doctors report screeningHalpern-Felsher (2000)41
Alcohol misuseDoctors report screening 84% of those aged 15–18 years in preventive examEllen (1998)43
28% of users report discussing it with clinicianKlein (2002)44
Chlamydia (boys)12.8% of primary care doctors report screeningSt. Lawrence (2002)40
Gonorrhea (boys)13.4% of primary care doctors report screeningSt. Lawrence (2002)40
HIV (low-risk)No data
Lipid disordersNo data
Illicit drug useDoctors report screening 82% of those aged 15–18 years in preventive examEllen (1998)43
37% of recent drug users reported having discussed drugs with their clinicianKlein (2002)44
Counseling
Physical activity42%–48% of those aged 13–17 years report a clinic conversationBethel (2001)45
83% of those aged 14–18 years report clinician discussion during a just-completed well visitKlein (2006)20
22.3% have NAMCS visit documentationMa (2005)11
34% of sedentary report discussing with clinicianKlein (2002)44
Healthy diet26%–32% of those aged 13–17 years report a clinic conversationBethel (2001)45
25.8% have NAMCS visit documentationMa (2005)11
Skin cancer3.2% have NAMCS visit documentationMa (2005)11
HIV and STIs36.4% of those aged 14–18 years report a clinic conversationBethel (2001)46
5.1% have NAMCS visit documentationMa (2005)11
Tobacco use23% of those aged 13–17 years report a clinic conversationBethel (2001)45
11.4% have NAMCS visit documentationMa (2005)11
40% of users report discussing it with clinicianKlein (2002)44
Vehicle restraints14.9% have NAMCS visit documentation of “injury prevention”Ma (2005)11
Any health counseling39% of those aged 13–18 years have NAMCS counseling documented during general medical exam visitsMa (2005)11

HEDIS, Healthcare Effectiveness Data and Information Set; NAMCS, National Ambulatory Medical Care Survey; STIs, sexually transmitted infections

Opportunities for Prevention 

Identifying published information about the frequency with which adolescents have medical encounters, either for routine exams or for illness, is an easier task than finding current delivery prevalence. A review11 of National Ambulatory Medical Care Survey (NAMCS) medical visit data for 1993–2000 found that adolescents aged 13–18 years averaged 1.9 total medical visits per year, less than any other age group except those aged 19–24 years (e.g., those aged 25–64 years averaged 3.1 and those aged ≥65 years averaged 6.1). That average of 1.9 visits for the adolescents varied substantially among subgroups. For example, it was 1.7 for boys, 2.2 for girls, 2.4 for whites, 1.5 for blacks, 1.2 for Hispanics and Asians, and only 0.3 for Native Americans. General medical exams accounted for 7.5% of adolescent visits, but boys had another 3.7% for physical exams for extracurricular activities. A review47 of NAMCS data for 1994–2003 found that 9% of adolescent visits were for preventive care, but the rate declined after age 14 years for girls and 13 years for boys. They found that “more than three times as many preventive visits were made by early adolescents as by late adolescents.”

An analysis48 of data from the national 1999 youth risk behavior surveillance survey of high school students found that, of those reporting a preventive care visit in the preceding 12 months, only 43% of girls and 26% of boys reported having discussed STIs, HIV, or pregnancy prevention at those visits. Thus, even those who report having preventive visits are missing opportunities to receive effective preventive services.

Another national survey, the national health interview survey, found that 90% of insured adolescents in 1995 had at least one physician contact in the past year (M=2.8).12 However, only 75% of uninsured adolescents (representing 14% of all adolescents) had been seen by a physician during the same period (M=1.5 contacts). In a survey10 of 6748 adolescents in 1997, 85% said they had had a well visit in the past year, 9% said 1–2 years ago, and 6% said more than 2 years ago. However, for those with no insurance, the rates were 76%, 12%, and 12%, respectively.

In a prepaid HMO system (Kaiser Portland) where insurance is not a limiting factor, 69% of those aged 14–17 years had a primary care visit during a 1-year period and 83% during a 2-year period (85% for girls and 81% for boys).13 Primary care visits accounted for 90% of all visits. Those who made primary care visits averaged 2.5 such visits per year.

Discussion 

return to Article Outline

Although the USPSTF has reviewed 24 CPS for adolescents, only seven have sufficient evidence to recommend their routine use, and five of these relate to sexual health. In addition, the ACIP has found good evidence for six immunizations relevant to this age group. The evidence-based services with the broadest application among adolescents are as follows:


1.cervical cancer screening at least every 3 years for all sexually active women;

2.chlamydia screening for all sexually active women under the age of 25;

3.tobacco use and depression screening and brief interventions;

4.HPV, meningococcal, Tdap, and influenza immunizations;

5.In addition, gonorrhea, syphilis, and HIV screening plus pneumococcus and hepatitis A immunizations are needed for groups at increased risk.

Despite the obvious need for more evidence for the services that received I or C grades from the USPSTF for this age group, few relevant studies were found in the current update of the literature, and none of the services gained any strength from subsequent studies, except for depression screening and tobacco counseling.

Summaries of the unknowns and evidence gaps for both screening and counseling services with an I grade for insufficient evidence demonstrated a lack of support for making the critical decision as to whether the magnitude of benefits clearly outweighs harms. In most cases, there is little definitive information about either benefits or harms. Without a surge of new, strong evidence, there will continue to be little evidentiary basis for providing adolescents with many CPS beyond immunizations and STIs.

Deficiencies in supportive evidence are also apparent in the limited and generally poor-quality data on current prevalence of delivering any of these services. Even among the recommended services, only Pap screening for cervical cancer is performed at a high prevalence, and that service is primarily aimed at older adolescents and women <65 years, with no data specifically for adolescents. For many of the other services, either there are no national data or the data are based on unreliable or incomplete sources, as in the following cases:


1.Clinician self-report studies continue to be conducted and published, although results may reflect intention to provide the service more than actual delivery of the service.49, 50

2.Patient reports of receiving advice during medical encounters are fairly useful, especially if collected very soon after the service, but they can be unreliable.51 Moreover, when reported at a general level (e.g., X% reported a conversation about physical activity), it is impossible to differentiate passing comments from a serious effort to affect behavior.

3.NAMCS data are relatively reliable for procedures and tests, but they are much worse for counseling services because of patient recall problems.52

4.Clinician documentation of counseling services in medical records seriously underestimates performance.53

Even considering the difficulties of under- and over-estimation, the delivery prevalences illustrated in Table 5 are insufficient. Thus, there are currently many adolescent CPS—most of which lack evidence supporting their effectiveness—being delivered at low prevalences with no relationship between prevalence and effectiveness.

Finally, there is literature about the frequency with which adolescents are seen in medical settings, but the average visit rates per year are low (1–2/year), and only a small proportion (10%) of these visits are for preventive services. Thus, the continued emphasis among national guidelines for frequent prevention visits appears to have been relatively ineffective, and restricting preventive services to these visits is unlikely to improve the low–delivery prevalence problem.

Recommendations 


1.Develop the evidence for adolescent CPS, especially those that address health conditions with a large impact. From a public policy perspective, it should be a national priority to develop the evidence needed for adolescent CPS, at least for those services that address conditions with a large health impact. Such an effort would require both additional resources for such research and a shift in funding priorities for the federal and private agencies that fund prevention research. Unfortunately, the CPS without an evidence base are typically those that address the greatest risks and problems for adolescents and their future health.

2.Prioritize CPS improvement efforts for those adolescent CPS with good evidence of effectiveness. While the policy, funding, and research communities are expanding the evidence base for these I- and C-graded services, the health plans, payers, care systems, and clinicians can do several things to improve delivery of services that have good evidence of effectiveness. First, the large number of CPS recommended for adolescents by professional associations without adequate evidence has led most care systems and clinicians to dilute their limited prevention time and energy to the point where no core set of services gets serious attention. One strategy for improvement would be to focus special attention on delivering those services with A or B evidence grades. During every prevention visit, staff can review whether these services are needed and remind the clinician about those needing further attention. Care systems and payers might foster such a focus on evidence-based services by providing incentives for the evidence-based services. An even more drastic approach would be to not reimburse services without evidence of effectiveness. This might stimulate the advocates for evidence-lacking CPS to encourage the additional research needed for these services.

3.Take advantage of every medical encounter with adolescents to address CPS needs.

Several national organizations continue to emphasize increasing preventive or well-child visits. However, because most adolescents do not have well-child visits at recommended intervals, especially after age 12 years, it would be better to take advantage of every medical encounter for evaluating prevention needs and providing services.13, 47 This approach is largely responsible for the improvements seen for childhood immunization prevalence, and it becomes more feasible with a limited number of priority services. There has been a clear movement in this direction for adult CPS, but it does not appear to be part of current practice for children and adolescents. As many as 80% of adolescents' encounters with healthcare providers do not include CPS interventions.54 GAPS (AMA), Bright Futures (AAP), and the Society for Adolescent Medicine appear to focus entirely on these well-child visits for delivering preventive services.16, 55 Because the literature suggests that only about 5%–10% of adolescent visits are for routine exams, discussing even one preventive service during most of the other 90% of visits could dramatically improve delivery prevalences.56, 57 Unlike most well-child visits in the first 10 years of life, many adolescent well visits are performed to satisfy school or sports requirements, so it is tempting to focus on completing the required forms rather than on the most important general preventive services.

Delivery of services for STIs to adolescents is complicated even more by the social milieu in which it happens. Legally, older adolescents are caught between childhood and adulthood. Although all states allow adolescents to consent to STI testing, age of consent and confidentiality laws involving STI-related medical visits and contraception vary considerably among states. In addition, commercial health plans are mandated by insurance laws to provide “explanation of benefits” (EOB) statements to the policy holder, generally a parent or guardian, that document payment for services received. Although EOB statements do not list diagnoses, they do indicate that the adolescent had a medical visit and provide some detail about services ordered (e.g., lab tests). Because of these two factors, many adolescents either seek sexual or reproductive health services at freestanding STI or family-planning clinics rather than their routine source of medical care or they do not seek such services at all. Moreover, because STI clinics are not oriented toward providing comprehensive preventive care, adolescent care tends to become even more fragmented. This makes it even more important for primary care medical clinics to take advantage of every visit for prevention.


4.Focus on implementing practice systems for CPS. Most importantly, for the above strategies to be successful, all of the stakeholders in improving CPS delivery for adolescents need to emphasize the critical role of practice systems.58 Such systems delegate as much as possible to support staff, specifying in their job description and standing orders the need to systematically assess the need for CPS during all encounters. Staff can then either remind the clinician or perform/schedule any needed services themselves. If the service (e.g., immunizations, screening tests) can be performed by staff on standing orders without reminding the clinician, it is much more likely to be performed.

The evidence for the importance of such systems has been strong for at least 15 years.59, 60, 61, 62, 63, 64, 65, 66, 67 Despite that, practice systems remain largely missing from most practices, and much of the research literature on guideline implementation has largely ignored systems.68, 69, 70, 71, 72, 73, 74 It is now abundantly clear that exhortation, education and training, and guideline dissemination alone will not produce much change in delivery prevalence.59, 75, 76, 77 Many studies that are entitled educational interventions usually focus that education on building practice systems, usually without making that point clearly.78, 79 Payment changes, incentives, and feedback of comparative performance measures may increase the desire of individual clinicians and group practices to improve, but to succeed, they will need effective practicewide systems.80, 81, 82, 83, 84, 85, 86, 87, 88, 89 These systems must both remind clinicians of their key roles (especially in counseling services) and greatly expand delegation and team approaches.81 It also appears that the Chronic Care Model provides a reasonable framework for conceptualizing the systems needed for CPS as well as chronic conditions.90 It has been demonstrated that external interventions can facilitate system implementation and care change, but it is less clear who would pay for such interventions outside the research environment.90, 91, 92, 93

Conclusion 

return to Article Outline

Too many CPS are recommended for adolescents with insufficient evidence of effectiveness, low delivery prevalence for even those services with good evidence, and too little attention to the practice changes that might improve those delivery prevalences. Adolescent CPS represent a neglected domain in many ways—it is time to change that.

 

return to Article Outline

This research was supported by Partnership for Prevention, Washington DC.

No financial disclosures were reported by the authors of this paper.

References 

return to Article Outline

1. 1McGinnis JM, Foege WH. Actual causes of death in the U.S. JAMA. 1993;270(18):2207–2212. MEDLINE

2. 2Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the U.S., 2000. JAMA. 2004;291(10):1238–1245. CrossRef

3. 3Cutler DM, Rosen AB, Vijan S. The value of medical spending in the U.S., 1960–2000. N Engl J Med. 2006;355(9):920–927. CrossRef

4. 4Bodenheimer T. High and rising health care costs (Part 1: seeking an explanation). Ann Intern Med. 2005;142(10):847–854.

5. 5Moyer VA, Butler M. Gaps in the evidence for well-child care: a challenge to our profession. Pediatrics. 2004;114(6):1511–1521.

6. 6Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention?. Am J Public Health. 2003;93(4):635–641. MEDLINE | CrossRef

7. 7Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314–2321. MEDLINE | CrossRef

8. 8Coffield AB, Maciosek MV, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001;21(1):1–9. Abstract | Full Text | Full-Text PDF (407 KB) | CrossRef

9. 9Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31(1):52–61. Abstract | Full Text | Full-Text PDF (106 KB) | CrossRef

10. 10Klein JD, Wilson KM, McNulty M, Kapphahn C, Collins KS. Access to medical care for adolescents: results from the 1997 Commonwealth Fund Survey of the Health of Adolescent Girls. J Adolesc Health. 1999;25(2):120–130. | CrossRef

11. 11Ma J, Wang Y, Stafford RSUS. adolescents receive suboptimal preventive counseling during ambulatory care. J Adolesc Health. 2005;36(5):441.

12. 12Newacheck PW, Brindis CD, Cart CU, Marchi K, Irwin CE. Adolescent health insurance coverage: recent changes and access to care. Pediatrics. 1999;104(2 Pt 1):195–202.

13. 13O'Connor EA, Hollis JF, Polen MR, Lichtenstein E. Adolescent health care visits: opportunities for brief prevention messages. Eff Clin Pract. 1999;2(6):272–276. MEDLINE

14. 14Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? (A framework for improvement). JAMA. 1999;282(15):1458–1465. MEDLINE | CrossRef

15. 15Chuang KH, Luft HS, Dudley RA. The clinical and economic performance of prepaid group practice. In:  Enthoven A,  Tollen L editor. Toward a 21st century health system: the contributions and promise of prepaid group practice. San Francisco CA: Jossey-Bass; 2004;p. 45–60.

16. 16Rosen DS, Elster A, Hedberg V, Paperny D. Clinical preventive services for adolescents: position paper of the Society for Adolescent Medicine. J Adolesc Health. 1997;21(3):203–214. | CrossRef

17. 17Recommendations and Guidelines: Advisory Committee on Immunization Practices (ACIP). Advisory Committee on Immunization Practices. www.cdc.gov/vaccines/recs/acip.

18. 18Barton MB, Miller T, Wolff T, et al. How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(2):123–127.

19. 19Taveras EM, Sobol AM, Hannon C, Finkelstein D, Wiecha J, Gortmaker SL. Youths' perceptions of overweight-related prevention counseling at a primary care visit. Obesity (Silver Spring). 2007;15(4):831–836. MEDLINE | CrossRef

20. 20Klein JD, Postle CK, Kreipe RE, et al. Do physicians discuss needed diet and nutrition health topics with adolescents?. J Adolesc Health. 2006;38(5):608.e1–608.e6. | CrossRef

21. 21Miranda R, Scott M, Hicks R, Wilcox HC, Harris Munfakh JL, Shaffer D. Suicide attempt characteristics, diagnoses, and future attempts: comparing multiple attempters to single attempters and ideators. J Am Acad Child Adolesc Psychiatry. 2008;47(1):32–40. Abstract | Full Text | Full-Text PDF (124 KB) | CrossRef

22. 22Folse VN, Eich KN, Hall AM, Ruppman JB. Detecting suicide risk in adolescents and adults in an emergency department: a pilot study. J Psychosoc Nurs Ment Health Serv. 2006;44(3):22–29. MEDLINE

23. 23Gould MS, Marrocco FA, Kleinman M, et al. Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial. JAMA. 2005;293(13):1635–1643. CrossRef

24. 24Boekeloo BO, Jerry J, Lee-Ougo WI, et al. Randomized trial of brief office-based interventions to reduce adolescent alcohol use. Arch Pediatr Adolesc Med. 2004;158(7):635–642. MEDLINE | CrossRef

25. 25Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med. 2006;145(8):564–572.

26. 26Gaydos CA, Kent CK, Rietmeijer CA, et al. Prevalence of Neisseria gonorrhoeae among men screened for Chlamydia trachomatis in four U.S. cities, 1999–2003. Sex Transm Dis. 2006;33(5):314–319. MEDLINE | CrossRef

27. 27Ortega-Sanchez R, Jimenez-Mena C, Cordoba-Garcia R, Munoz-Lopez J, Garcia-Machado ML, Vilaseca-Canals J. The effect of office-based physician's advice on adolescent exercise behavior. Prev Med. 2004;38(2):219–226. MEDLINE | CrossRef

28. 28Patrick K, Calfas KJ, Norman GJ, et al. Randomized controlled trial of a primary care and home-based intervention for physical activity and nutrition behaviors: PACE+ for adolescents. Arch Pediatr Adolesc Med. 2006;160(2):128–136. MEDLINE | CrossRef

29. 29Patrick K, Sallis JF, Prochaska JJ, et al. A multicomponent program for nutrition and physical activity change in primary care: PACE+ for adolescents. Arch Pediatr Adolesc Med. 2001;155(8):940–946. MEDLINE

30. 30Norman GJ, Adams MA, Calfas KJ, et al. A randomized trial of a multicomponent intervention for adolescent sun protection behaviors. Arch Pediatr Adolesc Med. 2007;161(2):146–152. MEDLINE | CrossRef

31. 31Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K. HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med. 2007;5(4):298–304. CrossRef

32. 32Roye C, Perlmutter Silverman P, Krauss B. A brief, low-cost, theory-based intervention to promote dual method use by black and Latina female adolescents: a randomized clinical trial. Health Educ Behav. 2007;34(4):608–621. CrossRef

33. 33Jemmott JB, Jemmott LS, Braverman PK, Fong GT. HIV/STD risk reduction interventions for African American and Latino adolescent girls at an adolescent medicine clinic: a randomized controlled trial. Arch Pediatr Adolesc Med. 2005;159(5):440–449. MEDLINE | CrossRef

34. 34Sales JM, Milhausen RR, Diclemente RJ. A decade in review: building on the experiences of past adolescent STI/HIV interventions to optimise future prevention efforts. Sex Transm Infect. 2006;82(6):431–436. MEDLINE | CrossRef

35. 35Boekeloo BO, Schamus LA, Simmens SJ, Cheng TL, O'Connor K, D'Angelo LJ. A STD/HIV prevention trial among adolescents in managed care. Pediatrics. 1999;103(1):107–115.

36. 36A clinical practice guideline for treating tobacco use and dependence: 2008 update (A U.S. Public Health Service report). Am J Prev Med. 2008;35(2):158–176. Abstract | Full Text | Full-Text PDF (327 KB) | CrossRef

37. 37Hollis JF, Polen MR, Whitlock EP, et al. Teen reach: outcomes from a randomized, controlled trial of a tobacco reduction program for teens seen in primary medical care. Pediatrics. 2005;115(4):981–989.

38. 38USPSTF. Screening and treatment for major depressive disorder in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Peds. 2009;123:1223–1228.

39. 39NCQA. The state of health care quality: 2007. www.ncqa.org/Portals/0/Newsroom/SOHC/SOHC_08.pdf.

40. 40St Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of U.S. physicians. Am J Public Health. 2002;92(11):1784–1788. MEDLINE | CrossRef

41. 41Halpern-Felsher BL, Ozer EM, Millstein SG, et al. Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients?. Arch Pediatr Adolesc Med. 2000;154(2):173–179. MEDLINE

42. 42Ozer EM. The adolescent primary care visit: time to build on strengths. J Adolesc Health. 2007;41(6):519–520. | CrossRef

43. 43Ellen JM, Franzgrote M, Irwin CE, Millstein SG. Primary care physicians' screening of adolescent patients: a survey of California physicians. J Adolesc Health. 1998;22(6):433–438. | CrossRef

44. 44Klein JD, Wilson KM. Delivering quality care: adolescents' discussion of health risks with their providers. J Adolesc Health. 2002;30(3):190–195. | CrossRef

45. 45Bethell C, Lansky D, Fiorillo J. A portrait of adolescents in America, 2001: FACCT—Foundation for Accountability. Princeton NJ: Robert Wood Johnson Foundation; 2001;.

46. 46Bethell C, Klein J, Peck C. Assessing health system provision of adolescent preventive services: the Young Adult Health Care Survey. Med Care. 2001;39(5):478–490. MEDLINE | CrossRef

47. 47Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161(3):252–259. MEDLINE | CrossRef

48. 48Burstein GR, Lowry R, Klein JD, Santelli JS. Missed opportunities for sexually transmitted diseases, human immunodeficiency virus, and pregnancy prevention services during adolescent health supervision visits. Pediatrics. 2003;111(5 Pt 1):996–1001.

49. 49McPhee SJ, Bird JA. Implementation of cancer prevention guidelines in clinical practice. J Gen Intern Med. 1990;5(S5):S116–S122. MEDLINE | CrossRef

50. 50Henry RC, Ogle KS, Snellman LA. Preventive medicine: physician practices, beliefs, and perceived barriers for implementation. Fam Med. 1987;19(2):110–113. MEDLINE

51. 51Ward J, Sanson-Fisher R. Accuracy of patient recall of opportunistic smoking cessation advice in general practice. Tob Control. 1996;5(2):110–113. MEDLINE | CrossRef

52. 52Gilchrist VJ, Stange KC, Flocke SA, McCord G, Bourguet CC. A comparison of the National Ambulatory Medical Care Survey (NAMCS) measurement approach with direct observation of outpatient visits. Med Care. 2004;42(3):276–280. MEDLINE | CrossRef

53. 53Stange KC, Zyzanski SJ, Smith TF, et al. How valid are medical records and patient questionnaires for physician profiling and health services research? (A comparison with direct observation of patients visits). Med Care. 1998;36(6):851–867. MEDLINE | CrossRef

54. 54Igra V, Millstein SG. Current status and approaches to improving preventive services for adolescents. JAMA. 1993;269(11):1408–1412. MEDLINE

55. 55Klein JD, Allan MJ, Elster AB, et al. Improving adolescent preventive care in community health centers. Pediatrics. 2001;107(2):318–327.

56. 56Cohen D, DiCicco-Bloom B, Strickland PO, et al. Opportunistic approaches for delivering preventive care in illness visits. Prev Med. 2004;38(5):565–573. MEDLINE | CrossRef

57. 57Rebelsky MS, Sox CH, Dietrich AJ, Schwab BR, Labaree CE, Brown-McKinney N. Physician preventive care philosophy and the five year durability of a preventive services office system. Soc Sci Med. 1996;43(7):1073–1081. MEDLINE | CrossRef

58. 58Solberg LI, Kottke TE, Conn SA, Brekke ML, Calomeni CA, Conboy KS. Delivering clinical preventive services is a systems problem. Ann Behav Med. 1997;19(3):271–278. MEDLINE | CrossRef

59. 59Cohen SJ, Halvorson HW, Gosselink CA. Changing physician behavior to improve disease prevention. Prev Med. 1994;23(3):284–291. MEDLINE | CrossRef

60. 60Yano EM, Fink A, Hirsch SH, Robbins AS, Rubenstein LV. Helping practices reach primary care goals (Lessons from the literature). Arch Intern Med. 1995;155(11):1146–1156. MEDLINE

61. 61Solberg LI, Kottke TE. The prevention-oriented practice. In:  Ockene IS,  Ockene JK editor. Prevention of coronary heart disease: a skill-based approach. Boston: Little, Brown and Co; 1992;p. 468–490.

62. 62Thompson RS, Taplin SH, McAfee TA, Mandelson MT, Smith AE. Primary and secondary prevention services in clinical practice (Twenty years' experience in development, implementation, and evaluation). JAMA. 1995;273(14):1130–1135. MEDLINE

63. 63Carney PA, Dietrich AJ, Keller A, Landgraf J, O'Connor GT. Tools, teamwork, and tenacity: an office system for cancer prevention. J Fam Pract. 1992;35(4):388–394. MEDLINE

64. 64Leininger LS, Finn L, Dickey L, et al. An office system for organizing preventive services: a report by the American Cancer Society Advisory Group on Preventive Health Care Reminder Systems. Arch Fam Med. 1996;5(2):108–115. MEDLINE

65. 65Hulscher ME, Wensing M, Grol RP, van der Weijden T, van Weel C. Interventions to improve the delivery of preventive services in primary care. Am J Public Health. 1999;89(5):737–746. MEDLINE | CrossRef

66. 66Dickey LL, Gemson DH, Carney P. Office system interventions supporting primary care-based health behavior change counseling. Am J Prev Med. 1999;17(4):299–308. Abstract | Full Text | Full-Text PDF (168 KB) | CrossRef

67. 67Dexheimer JW, Talbot TR, Sanders DL, Rosenbloom ST, Aronsky D. Prompting clinicians about preventive care measures: a systematic review of randomized controlled trials. J Am Inform Assoc. 2008;15(3):311–320.

68. 68Solberg LI, Kottke TE, Brekke ML, Conn SA, Magnan S, Amundson G. The case of the missing clinical preventive services systems. Eff Clin Pract. 1998;1(1):33–38. MEDLINE

69. 69Solberg LI, Trangle MA, Wineman AP. Follow-up and follow-through of depressed patients in primary care: the critical missing components of quality care. J Am Board Fam Pract. 2005;18(6):520–527. MEDLINE

70. 70Margolis KL, Solberg LI, Asche SE, Whitebird RR. Use of practice system tools by medical groups for depression. Am J Manag Care. 2007;13(6):305–311.

71. 71McIlvain HE, Crabtree BF, Backer EL, Turner PD. Use of office-based smoking cessation activities in family practices. J Fam Pract. 2000;49(11):1025–1029. MEDLINE

72. 72Ellerbeck EF, Ahluwalia JS, Jolicoeur DG, Gladden J, Mosier MC. Direct observation of smoking cessation activities in primary care practice. J Fam Pract. 2001;50(8):688–693. MEDLINE

73. 73Casalino L, Gillies RR, Shortell SM, et al. External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases. JAMA. 2003;289(4):434–441. MEDLINE | CrossRef

74. 74Solberg LI. Guideline implementation: what the literature doesn't tell us. Jt Comm J Qual Improv. 2000;26(9):525–537. MEDLINE

75. 75Davis DA, Taylor-Vaisey A. Translating guidelines into practice (A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines). Can Med Assoc J. 1997;157(4):408–416.

76. 76Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993;329(17):1271–1273. MEDLINE | CrossRef

77. 77Thompson C, Kinmonth AL, Stevens L, et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet. 2000;355(9199):185–191. CrossRef

78. 78Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17(3):283–295. MEDLINE | CrossRef

79. 79Vacek JL. Practice-based continuing education combined with process improvement methods improves delivery of preventive services to children. Evid Based Healthc. 2004;8(4):177.

80. 80Elford RW, Jennett P, Bell N, Szafran O, Meadows L. Putting prevention into practice. Health Rep. 1994;6(1):142–153. MEDLINE

81. 81Dietrich AJ, Carney PA, Winchell CW, Sox CH, Reed SC. An office systems approach to cancer prevention in primary care. Cancer Pract. 1997;5(6):375–381. MEDLINE

82. 82Bordley WC, Margolis PA, Stuart J, Lannon C, Keyes L. Improving preventive service delivery through office systems. Pediatrics. 2001;108(3):E41.

83. 83Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med. 2002;136(9):641–651.

84. 84Goodwin MA, Zyzanski SJ, Zronek S, et al. A clinical trial of tailored office systems for preventive service delivery (The Study to Enhance Prevention by Understanding Practice (STEP-UP)). Am J Prev Med. 2001;21(1):20–28. Abstract | Full Text | Full-Text PDF (156 KB) | CrossRef

85. 85Shannon KC, Sinacore JM, Bennett SG, Joshi AM, Sherin KM, Deitrich A. Improving delivery of preventive health care with the comprehensive annotated reminder tool (CART). J Fam Pract. 2001;50(9):767–771. MEDLINE

86. 86Underbakke G, McBride PE. Office systems for heart disease prevention. Prim Care. 2005;32(4):883–900. Full Text | Full-Text PDF (249 KB) | CrossRef

87. 87Andrews JO, Tingen MS, Waller JL, Harper RJ. Provider feedback improves adherence with AHCPR smoking cessation guideline. Prev Med. 2001;33(5):415–421. MEDLINE | CrossRef

88. 88Grimshaw J, Eccles M, Thomas R, et al. Toward evidence-based quality improvement (Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966–1998). J Gen Intern Med. 2006;21(S2):S14–S20. CrossRef

89. 89Hillman AL, Ripley K, Goldfarb N, Nuamah I, Weiner J, Lusk E. Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. Am J Public Health. 1998;88(11):1699–1701. MEDLINE | CrossRef

90. 90Glasgow RE, Orleans CT, Wagner EH, Curry SJ, Solberg LI. Does the chronic care model serve also as a template for improving prevention?. Milbank Q. 2001;79(4):579–612iv–v.

91. 91Lobo CM, Frijling BD, Hulscher ME, et al. Improving quality of organizing cardiovascular preventive care in general practice by outreach visitors: a randomized controlled trial. Prev Med. 2002;35(5):422–429. MEDLINE | CrossRef

92. 92Elwyn G, Rhydderch M. Achieving organizational change in primary care: simmer gently for two years. Prev Med. 2002;35(5):419–421. MEDLINE | CrossRef

93. 93Hung DY, Rundall TG, Tallia AF, Cohen DJ, Halpin HA, Crabtree BF. Rethinking prevention in primary care: applying the chronic care model to address health risk behaviors. Milbank Q. 2007;85(1):69–91. CrossRef

a HealthPartners Research Foundation, Minneapolis, Minnesota

b Partnership for Prevention, Washington, District of Columbia

Corresponding Author InformationAddress correspondence and reprint requests to: Leif I. Solberg, MD, HealthPartners Research Foundation, P.O. Box 1524, MS #21111R, Minneapolis MN 55440-1524

 The full text of this article is available via AJPM Online at www.ajpm-online.net.

PII: S0749-3797(09)00490-5

doi:10.1016/j.amepre.2009.06.017


View previous. 11 of 17 View next.